Central African Republic vs United States of America: Cases started on MDR-TB treatment
Central African Republic
184
in 2024
United States of America
175
in 2023
Central African Republic rank
51st
United States of America rank
53rd
Cases started on MDR-TB treatment over time
- Central African Republic
- United States of America
How they compare
Central African Republic currently reports 184 against 175 in United States of America, a difference of 9.
That makes Central African Republic's figure about 1.1 times United States of America's.
The two have swapped places 2 times across 15 shared years of data; in 2008 it was United States of America ahead.
Central African Republic ranks 51st and United States of America ranks 53rd of 193 countries.
United States of America has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 64 | 64 | United States of America |
| 2010s | 38.11 | 103.11 | 65 | United States of America |
| 2020s | 101.75 | 109.75 | 8 | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Central African Republic or United States of America?
- Central African Republic, at 184 against 175 in United States of America as of 2024.
- What is the difference in cases started on mdr-tb treatment between Central African Republic and United States of America?
- 9, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and United States of America?
- 15 years are reported by both, from 2008 to 2023.
- How do Central African Republic and United States of America rank globally for cases started on mdr-tb treatment?
- Central African Republic ranks 51st and United States of America ranks 53rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.